Creative Medical Technology (CELZ) announced mid-term follow-up data from its StemSpine pilot study utilizing its AlloStem cells for the treatment of chronic lower back pain. The pilot study ...
PHOENIX, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company advancing regenerative medicine solutions, today ...
Creative Medical Technology (CELZ) announced an expanded agreement with Greenstone Biosciences to leverage Artificial Intelligence in further developing its human induced pluripotent stem cell ...
PHOENIX, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical”), a clinical-stage biotechnology company advancing regenerative medicine ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback